The GCDH gene helps your body break down parts of protein, especially lysine, hydroxylysine, and tryptophan. If it does not work properly, certain acids can build up and may harm the brain, particularly during infancy and early childhood. Pathogenic variants in the GCDH gene cause glutaric acidemia type 1, a condition that can lead to low muscle tone, movement problems, and episodes of sudden worsening during illness or fasting. Early diagnosis and treatment can help reduce complications.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for building proteins, which are the parts of cells that do much of the work. Others mainly guide when certain activities happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. To look into this subject more closely, you can find more in the LearnHub.
Overview
GCDHGene function
What if the gene works
The GCDH gene helps your body break down lysine, hydroxylysine, and tryptophan, which are building blocks of protein. This supports energy production and helps prevent a harmful substance called glutaric acid from building up.
Risk
What if the gene does not work
Milder to more severe variants in the GCDH gene can cause glutaric acidemia type 1. The body cannot fully break down amino acids, and toxic buildup may lead to movement problems, low muscle tone, and developmental delay, often from infancy.
Treatment
What does that mean for your treatment
Pathogenic variants in the GCDH gene support prompt, guideline-based metabolic treatment rather than a variant-specific drug choice. Care usually includes a low-lysine diet, carnitine, and an emergency illness plan with extra calories and temporary protein reduction to lower the chance of metabolic crises. Current care is generally similar across pathogenic GCDH variants.
Conditions associated with GCDH
Gene function
What if the gene works
Your body regularly breaks down parts of protein from food and from normal tissue turnover. In that process, the GCDH gene helps your cells handle specific amino acids, especially lysine, hydroxylysine, and tryptophan. Understanding how the GCDH gene helps break down certain amino acids shows how cells keep metabolism moving in a steady way.
The GCDH gene carries the recipe for an enzyme used in normal protein metabolism. Your cells make this enzyme mainly inside mitochondria, where many fuel processing steps take place.
This enzyme handles glutaryl-CoA, a small chemical made while breaking down lysine, hydroxylysine, and tryptophan. That helps these amino acid parts keep moving through the body’s usual chemical pathway.
By completing this step, the enzyme helps cells recover usable carbon and energy from amino acids. This supports steady day to day metabolism across many tissues.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GCDH gene often change the shape or stability of the GCDH enzyme, sharply reducing its activity or stopping it completely. Some GCDH gene variants leave a little activity, while more severe variants lead to almost none. This can help explain why glutaric acidemia type 1 starts earlier or appears more strongly in some people. Certain variants also disrupt enzyme assembly or make the protein break down too soon.
How variants are linked to conditions
Pathogenic variants in the GCDH gene cause glutaric acidemia type 1, a rare inherited condition often found through newborn screening or genetic testing. People with two disease-causing variants may develop low muscle tone, movement problems, or developmental difficulties, and some have sudden worsening during illness in infancy or early childhood. In this setting, a GCDH gene variant linked to glutaric acidemia type 1 can confirm the diagnosis when test results fit the clinical picture.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of human biology. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some instances, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GCDH, the main risk comes from inheriting two changed copies of the gene, one from each parent. In people living with GCDH-related illness, fasting, infections, and other body stress can raise the chance of a sudden serious illness, especially in early childhood. Early diagnosis and careful sick-day planning can help lower the chance of complications.
Inheritance of GCDH variants
Variants in the GCDH gene are inherited in an autosomal recessive pattern, which is the inheritance pattern for GCDH-related glutaric acidemia type 1. This means a child inherits one changed copy from each parent. Parents who each carry one GCDH gene variant usually do not have the condition, but with each pregnancy there is a 25% chance the child will inherit both variants and have the condition, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. Sons and daughters are affected equally because this GCDH inheritance pattern does not involve a sex chromosome.
What does my GCDH result mean for my family?
For families, a GCDH result often means close relatives may also be carriers, even if they have never had symptoms. Brothers and sisters could also have the condition or be carriers, depending on their own gene results. Family members who are planning children may want to learn whether they carry the same change, because this can affect the chance of having a child with glutaric acidemia type 1.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the GCDH gene, doctors use GCDH genetic testing on a blood, saliva, or cheek swab sample. The lab reads the gene's DNA code and may also check for missing or extra pieces, which can confirm a diagnosis or show whether someone is a carrier.
When should I consider getting a genetic test?
Consider GCDH testing if a baby has a positive newborn screening result for glutaric acidemia type 1, or if this inherited condition runs in the family. It can also help explain symptoms such as low muscle tone, unusual movements, or developmental delay.
A genetic result is only one part of your health story
A genetic result can provide useful information, but how much it explains varies with the condition and the kind of variant involved. Over time, how the body works is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results may help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication may work well for one person, do less for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect responses to medicines. It focuses on connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. To look into this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the GCDH gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so general questions about side effects, new symptoms, or medication changes are best discussed with your doctor or pharmacist. Seek medical advice promptly if you feel worse after starting a treatment or if symptoms change in a way that affects daily life.
History
The GCDH gene entered medical genetics through work on glutaric acidemia type 1, a rare inherited condition first recognized from unusual chemical patterns in urine and blood. From these first observations, research expanded steadily. In the late 20th century, scientists linked the condition to changes in the GCDH gene, which helped confirm the cause in many affected families and improved diagnosis. As DNA testing became more widely used, doctors could identify carriers and diagnose some children earlier, often before major symptoms appeared. Over time, this gene became an important example of how careful metabolic testing and genetic studies can work together to clarify an inherited condition.